Global Cardiopulmonary Resuscitation Device Market Insights and Forecast to 2028

SKU ID : QYR-20124466 | Publishing Date : 24-Jan-2022

Cardiopulmonary resuscitation (CPR) is an emergency procedure that combines chest compressions often with artificial ventilation in an effort to manually preserve intact brain function until further measures are taken to restore spontaneous blood circulation and breathing in a person who is in cardiac arrest. It is recommended in those who are unresponsive with no breathing or abnormal breathing, for example, agonal respirations.
Market Analysis and Insights: Global Cardiopulmonary Resuscitation Device Market
Due to the COVID-19 pandemic, the global Cardiopulmonary Resuscitation Device market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Manual accounting for % of the Cardiopulmonary Resuscitation Device global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Cardiopulmonary Resuscitation Device market size is valued at US$ million in 2021, while the US and Europe Cardiopulmonary Resuscitation Device are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Cardiopulmonary Resuscitation Device landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Cardiopulmonary Resuscitation Device include Asahi Kasei, Corpuls, CU Medical Systems, GE Healthcare, Nihon Kohden, Stryker, Zoll Medical, Abbott and Michigan Instruments, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Cardiopulmonary Resuscitation Device Scope and Segment
Cardiopulmonary Resuscitation Device market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Cardiopulmonary Resuscitation Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Manual
Automatic
Segment by Application
Hospital
Pre Hospital
Others
By Company
Asahi Kasei
Corpuls
CU Medical Systems
GE Healthcare
Nihon Kohden
Stryker
Zoll Medical
Abbott
Michigan Instruments
Phillips
Physio Control
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
market Reports market Reports